Related Experiment Video
Updated: Aug 11, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Effect of corticosteroids or diuretics in low-tone sensorineural hearing loss
Mitsuya Suzuki1, Rika Otake, Akinori Kashio
1Department of Otolaryngology, Tokyo Metropolitan Police Hospital, Fujimi, Tokyo, Japan. misuzuki-tky@umin.ac.jp
Objectives:
We retrospectively analyzed 225 patients with acute low-tone sensorineural hearing loss (ALSHL), comparing the effectiveness of corticosteroid and diuretic therapy, and also determining the factors affecting hearing recovery.
Design:
Retrospective clinical record review.
Methods:
Multivariate logistic regression analysis.
Results:
Analyses identified unfavorable factors such as aging, late initiation of treatment, and pretreatment pure-tone hearing thresholds at three lower frequencies adding up to 95 dB and more. Multivariate logistic regression analysis indicated a significantly greater improvement in hearing in patients treated with corticosteroids at high initial and total doses than in those treated with vitamin B12 and ATP without adding corticosteroids. In 145 patients treated with corticosteroids, multivariate logistic regression analysis showed a trend toward greater improvement with high initial and total doses than with low doses.
Conclusion:
Corticosteroids should be changed from low to high doses within 7 days after onset of ALSHL, if low doses are failing.
More Related Videos
09:18A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
06:55A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus)
Published on: February 27, 2018
Related Concept Videos
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Thiazide-Class Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Heart Failure VI: Adjunct Therapies